XenoHeart

Product

by United Therapeutics Corporation

XenoHeart is a genetically modified pig heart developed for cardiac xenotransplantation, intended to provide a potential alternative source of donor hearts for people with end-stage heart failure. It is an investigational biomedical product and is being developed through United Therapeutics’ xenotransplantation programs; it is not an approved commercial transplant product.